Cite
HARVARD Citation
Chi, K. et al. (2018). Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial. Lancet oncology. 19 (2), pp. 194-206. [Online].